https://sentiholdings.com/james-collins-ph-d-2/ 2023-12-11T21:10:03+00:00 https://sentiholdings.com/michael-andreeff-m-d-ph-d/ 2023-12-11T21:10:07+00:00 https://sentiholdings.com/michael-kalos-ph-d/ 2023-12-11T21:10:23+00:00 https://sentiholdings.com/michael-varney-ph-d/ 2023-12-11T21:10:33+00:00 https://sentiholdings.com/robin-g-taylor-m-b-a-ph-d/ 2023-12-11T21:10:38+00:00 https://sentiholdings.com/iterative-engineering-of-polarization-state-responsive-synthetic-promoters-for-autonomous-control-of-macrophage-polarization-logic/ 2024-06-04T23:00:42+00:00 https://sentiholdings.com/discovery-of-novel-cars-for-solid-tumors-using-senti-reveal/ 2024-06-04T23:02:06+00:00 https://sentiholdings.com/precision-off-the-shelf-natural-killer-cell-therapies-for-oncology-with-logic-gated-gene-circuits/ 2024-06-04T23:03:02+00:00 https://sentiholdings.com/calibrated-release-il15-expressing-bivalent-cd33-and-or-flt3-logic-gated-gene-circuit-car-nk-cell-therapy-from-senti-202-gene-circuit-in-venetoclax-resistant-patient-derived-xenograft-acute-myeloid/ 2024-06-04T23:04:25+00:00 https://sentiholdings.com/calibrated-release-il15-expressing-bivalent-cd33-and-or-flt3-logic-gated-gene-circuit-car-nk-cell-therapy-from-senti-202-gene-circuit-in-venetoclax-resistant-patient-derived-xenograft-acute-myeloid-2/ 2024-06-04T23:05:12+00:00 https://sentiholdings.com/high-throughput-discovery-of-constitutive-promoters-to-drive-strong-expression-of-next-generation-gene-circuits-in-car-nk-and-t-cells/ 2024-06-04T23:06:22+00:00 https://sentiholdings.com/not-gate-gene-circuits-expand-the-range-of-tumor-associated-antigens-addressable-by-car-nk-and-t-cell-therapies/ 2024-06-04T23:06:37+00:00 https://sentiholdings.com/massively-parallel-and-systematic-engineering-platform-for-highly-compact-cell-type-specific-and-potent-smart-sensor-promoters-for-precision-retinal-gene-therapies/ 2024-06-04T23:07:45+00:00 https://sentiholdings.com/high-throughput-engineering-of-logic-gated-gene-circuits-for-precision-car-cell-therapies/ 2024-06-04T23:08:09+00:00 https://sentiholdings.com/designing-cell-state-specific-synthetic-promoters-as-smart-sensors-to-control-macrophage-polarization/ 2024-06-04T23:08:28+00:00 https://sentiholdings.com/off-the-shelf-car-nk-cells-engineered-to-express-calibrated-release-il-15-exhibit-enhanced-persistence-and-anti-tumor-activity/ 2024-06-04T23:08:52+00:00 https://sentiholdings.com/senti-202-a-selective-off-the-shelf-preclinical-car-nk-cell-therapy-with-cd33-and-or-flt3-activating-car-healthy-cell-protection-from-endomucin-emcn-inhibitory-car-and-calibrated-release-il-15-f/ 2024-06-04T23:09:25+00:00 https://sentiholdings.com/selection-of-lead-development-off-the-shelf-car-nk-candidate-senti-301a-for-gpc3-program-and-expansion-of-regulator-dial-gene-circuits-to-tackle-key-challenges-in-solid-tumors/ 2024-06-04T23:09:39+00:00 https://sentiholdings.com/implantable-synthetic-cytokine-converter-cells-with-and-gate-logic-treat-experimental-psoriasis/ 2024-06-04T23:11:18+00:00 https://sentiholdings.com/a-programmable-synthetic-lineage-control-network-that-differentiates-human-ipscs-into-glucose-sensitive-insulin-secreting-beta-like-cells/ 2024-06-04T23:11:29+00:00 https://sentiholdings.com/synthetic-rna-based-immunomodulatory-gene-circuits-for-cancer-immunotherapy/ 2024-06-04T23:11:43+00:00 https://sentiholdings.com/generalized-extracellular-molecule-sensor-platform-for-programming-cellular-behavior/ 2024-06-04T23:11:57+00:00 https://sentiholdings.com/universal-chimeric-antigen-receptors-for-multiplexed-and-logical-control-of-t-cell-responses/ 2024-06-04T23:12:07+00:00 https://sentiholdings.com/development-of-logic-gated-car-nk-cells-to-reduce-target-mediated-healthy-tissue-toxicities/ 2024-06-04T23:12:18+00:00 https://sentiholdings.com/precise-tumor-targeting-with-not-gate-chimeric-antigen-receptor-gene-circuits/ 2024-06-04T23:12:35+00:00 https://sentiholdings.com/precise-targeting-of-aml-with-first-in-class-or-not-logic-gated-gene-circuits-in-car-nk-cells/ 2024-06-04T23:12:53+00:00 https://sentiholdings.com/scalable-gmp-ready-manufacturing-process-for-gene-circuit-engineered-allogeneic-car-nk-cell-therapy-for-cancer/ 2024-06-04T23:13:22+00:00 https://sentiholdings.com/umbilical-cord-blood-derived-natural-killer-cells-provide-a-highly-scalable-source-for-gene-circuit-engineered-allogeneic-car-nk-therapies/ 2024-06-04T23:13:36+00:00 https://sentiholdings.com/development-of-logic-gated-car-nk-cells-for-the-treatment-of-solid-tumors/ 2024-06-04T23:13:46+00:00 https://sentiholdings.com/flt3-or-cd33-not-emcn-logic-gated-car-nk-cell-therapy-senti-202-for-precise-targeting-of-aml/ 2024-06-04T23:13:59+00:00 https://sentiholdings.com/driving-anti-tumor-activity-in-solid-tumors-with-controlled-arming-of-allogeneic-car-nk/ 2024-06-04T23:14:12+00:00 https://sentiholdings.com/process-development-and-scale-up-for-gene-circuit-engineered-car-nk-cell-manufacturing/ 2024-06-04T23:14:24+00:00 https://sentiholdings.com/activation-regulated-gene-circuit-for-controlling-payload-expression-in-cell-therapies/ 2024-06-04T23:14:40+00:00 https://sentiholdings.com/logic-gated-flt3-or-cd33-not-emcn-car-nk-cell-therapy-senti-202-for-precise-targeting-of-aml/ 2024-06-04T23:15:05+00:00 https://sentiholdings.com/senti-401-an-allogeneic-logic-gated-and-multi-armed-car-nk-cell-therapy-for-the-treatment-of-cea-expressing-solid-tumors-with-enhanced-selectivity-and-activity/ 2024-06-04T23:15:17+00:00 https://sentiholdings.com/precision-off-the-shelf-natural-killer-cell-therapies-for-oncology-with-logic-gated-gene-circuits-2/ 2024-08-15T17:06:59+00:00 https://sentiholdings.com/senti-301a-an-off-the-shelf-multi-armed-preclinical-car-nk-cell-therapy-for-the-treatment-of-gpc3-expressing-tumors/ 2024-10-18T16:50:28+00:00 https://sentiholdings.com/preclinical-development-of-senti-202-an-off-the-shelf-logic-gated-car-nk-cell-therapy-for-the-treatment-of-cd33-flt3-hematologic-malignancies-including-aml/ 2024-10-18T16:51:17+00:00 https://sentiholdings.com/james-collins-ph-d/ 2024-12-02T17:52:46+00:00 https://sentiholdings.com/fran-schulz/ 2024-12-02T17:53:05+00:00 https://sentiholdings.com/donald-tang/ 2025-01-07T18:59:50+00:00 https://sentiholdings.com/jay-cross/ 2025-02-25T13:00:59+00:00 https://sentiholdings.com/wp-content/uploads/2023/12/Jay-Cross-headshot-crop.jpg https://sentiholdings.com/feng-hsiung/ 2025-03-19T16:13:07+00:00 https://sentiholdings.com/james-b-trager-ph-d/ 2025-04-10T12:47:00+00:00 https://sentiholdings.com/first-in-human-multicenter-study-of-senti-202-a-cd33-flt3-selective-off-the-shelf-logic-gated-car-nk-cell-therapy-in-hematologic-malignancies-including-aml-correlative-data/ 2025-04-29T14:01:00+00:00 https://sentiholdings.com/senti-202-cd33-or-flt3-not-emcn-logic-gated-gene-circuit-components-selectively-target-aml-while-protecting-human-hsc-hpcs-from-off-tumor-toxicity-in-a-humanized-mouse-model/ 2025-04-30T14:01:00+00:00 https://sentiholdings.com/first-in-human-multicenter-study-of-senti-202-a-cd33-flt3-selective-off-the-shelf-logic-gated-car-nk-cell-therapy-in-hematologic-malignancies-including-aml-clinical-data/ 2025-05-05T20:27:18+00:00 https://sentiholdings.com/bryan-baum/ 2025-07-17T22:42:45+00:00 https://sentiholdings.com/smart-sensor-promoters-drive-state-specific-gene-circuits-to-convert-immunosuppressive-macrophages-into-an-anti-tumor-phenotype/ 2025-07-23T18:26:03+00:00 https://sentiholdings.com/timothy-lu-m-d-ph-d/ 2025-10-29T22:47:03+00:00 https://sentiholdings.com/wp-content/uploads/2023/12/timothy-lu.jpg https://sentiholdings.com/correlative-data-from-an-ongoing-phase-1-multicenter-study-of-senti-202-a-first-in-class-cd33-and-or-flt3-not-endomucin-emcn-selective-off-the-shelf-car-nk-cell-therapy-for-acute-myeloid-l/ 2025-12-08T18:35:23+00:00 https://sentiholdings.com/promising-results-from-an-ongoing-phase-i-multicenter-study-of-senti-202-a-first-in-class-cd33-and-or-flt3-not-endomucin-emcn-selective-off-the-shelf-logic-gated-car-nk-cell-therapy-in-adul/ 2025-12-08T18:37:21+00:00 https://sentiholdings.com/engineered-imid-regulated-synthetic-transcriptional-switch-for-controlled-and-dose-responsive-expression-of-therapeutic-payload-within-fda-approved-drug-doses/ 2026-10-26T18:14:53+00:00 https://sentiholdings.com/small-molecule-regulated-safety-switch-for-improved-safety-of-car-cell-therapies-in-the-brain/ 2026-10-26T18:15:11+00:00 https://sentiholdings.com/engineering-a-gene-circuit-enabled-cell-therapy-with-a-tamoxifen-regulated-safety-switch-for-inducible-cell-death-in-human-pluripotent-stem-cells-and-their-derivatives/ 2026-10-26T18:15:24+00:00 https://sentiholdings.com/engineering-pharmacologically-relevant-fda-approved-small-molecule-regulated-gene-circuits-for-therapeutic-applications-in-the-brain/ 2026-10-26T18:16:07+00:00 https://sentiholdings.com/multi-arming-and-regulator-dial-gene-circuits-to-address-key-disease-challenges-in-hcc/ 2026-10-26T18:16:18+00:00 https://sentiholdings.com/small-molecule-regulated-gene-circuit-for-controlling-cytokine-expression-in-cell-therapies/ 2026-10-26T18:16:29+00:00